Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

The Foundation for Innovative New Diagnostics (FIND), Molbio Diagnostics and the Indian Council of Medical Research (ICMR) announced today that the World Health Organization (WHO) has now endorsed ...

Franklin Lakes-based BD (Becton, Dickinson and Co.) on Aug. 25 announced the launch of a new, fully automated high-throughput diagnostic system for U.S. labs Using robotics and sample management ...

PLEASANTON, Calif., July 30, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® prime Pre-analytical System to improve efficiency in molecular diagnostics ...

BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global animal and public health, announced ...

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...

QuidelOrtho Corporation (NASDAQ:QDEL) has announced a strategic pivot in its molecular diagnostics business, seeking to acquire full ownership of LEX Diagnostics following projected 510(k) FDA ...

Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from manageable conditions to fatal diseases.

The current pandemic has impacted nearly every aspect of daily life. One strategy to help public health professionals understand and control the spread of SARS-CoV-2 is the widespread testing of ...

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as a diagnostic marker, a key ...